SGLT

11 Item(s)

per page

Set Descending Direction
  1. Dapagliflozin (BMS512148)

    Catalog No. A10285
    Quick View
    SGLT2 inhibitor
    Dapagliflozin inhibits subtype 2 of the sodium-glucose transport proteins (SGLT2), which is responsible for at least 90% of the glucose reabsorption in the kidney. Learn More
  2. T-1095

    Catalog No. A15463
    Quick View
    Na+-glucose transporter inhibitor
    T-1095 is a potent and selective inhibitor of Na+-glucose cotransporters (SGLTs). Learn More
  3. Luseogliflozin

    Catalog No. A13476
    Quick View
    SGLT2 Inhibitor
    Luseogliflozin is an orally active second-generation sodium-glucose co-transporter 2 (SGLT2) inhibitor developed by Taisho Pharmaceutical for the treatment of patients with type 2 diabetes mellitus (T2DM). Learn More
  4. Ipragliflozin

    Catalog No. A13556
    Quick View
    SGLT2 inhibitor
    Ipragliflozin is a highly potent and selective SGLT2 inhibitor with IC50 of 2.8 nM; little and NO potency for SGLT1/3/4/5/6. Learn More
  5. Remogliflozin

    Catalog No. A13971
    Quick View
    SGLT2 inhibitor
    Remogliflozin inhibits the sodium-glucose transport (SGLT2) proteins, which are responsible for glucose reabsorption in the kidney. Learn More
  6. Tofogliflozin

    Catalog No. A12690
    Quick View
    SGLT2 inhibitor
    Tofogliflozin is an inhibitor of subtype 2 sodium-glucose transport protein (SGLT2), which is responsible for at least 90% of the glucose reabsorption in the kidney. Learn More
  7. LX-4211

    Catalog No. A12680
    Quick View
    SGLT Inhibitor‎
    LX4211 is a Dual SGLT1/SGLT2 Inhibitor Learn More
  8. Empagliflozin

    Catalog No. A12440
    Quick View
    Empagliflozin is a potent, selective sodium glucose co-transporter-2 inhibitor that is in development for the treatment of type 2 diabetes. Learn More
  9. EGT1442

    Catalog No. A10155
    Quick View
    SGLT2 inhibitor
    EGT1442 is a potent and selective SGLT2 inhibitor. Learn More
  10. Canagliflozin

    Catalog No. A11100
    Quick View
    SGLT2 Inhibitor
    Canagliflozin is an inhibitor of subtype 2 sodium-glucose transport protein (SGLT2). Learn More
  11. Canagliflozin hemihydrate

    Catalog No. A16817
    Quick View
    SGLT2 inhibitor
    Canagliflozin hemihydrate is the hemihydrate form of canagliflozin, which is a SGLT2 inhibitor with IC50 of 2.2 nM for hSGLT2 in a cell-free assay, exhibits 413-fold selectivity over hSGLT1. Learn More

11 Item(s)

per page

Set Descending Direction
Rewards